Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 16c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $15 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Hewlett Packard Enterprise (HPE) call put ratio 2.2 calls to 1 put into quarter results
• Broadcom (AVGO) call put ratio 1.3 calls to 1 put into quarter results